
Dubai Investments' Globalpharma Expands into Angola
Dubai Investments' subsidiary Globalpharma partners with PrinceFarma to boost pharmaceutical distribution in Angola.


Dubai Investments' subsidiary Globalpharma partners with PrinceFarma to boost pharmaceutical distribution in Angola.

Explore a comprehensive financial analysis of Dubai Investments PJSC (DIC), covering trend analysis, technical analysis, and more, to understand the stock's performance and future potential.

Dubai Investments PJSC reports a remarkable 29% increase in profit before tax for the first half of 2026, driven by strong performance in key sectors.

Dubai Investments PJSC, a leading diversified investment company, has released its interim financial statements for the first half of 2026, showcasing impressive growth and strategic advancements.

Dubai Investments PJSC has acquired full ownership of Clemenceau Medical Center Dubai, marking a strategic milestone in the healthcare sector.

Dubai Investments PJSC has been awarded the Gold Tier in the Majra Impact Seal for its outstanding ESG practices.

Dubai Investments PJSC has extended its liquidity agreement with xCube LLC, ensuring continued market stability and enhanced shareholder value.

Dubai Investments PJSC (DIC), a prominent player in the UAE's multi-asset investment landscape, has demonstrated a diverse portfolio strategy. This article delves into a comprehensive financial analysis of DIC, exploring trends, technical indicators, support and resistance levels, volatility, and pattern recognition.

Globalpharma, a subsidiary of Dubai Investments, signs key MoUs to enhance R&D, manufacturing, and sustainability in the UAE pharmaceutical sector.

Dubai Investments PJSC demonstrates resilience with stable Q1 2026 performance, showcasing the strength of its diversified portfolio.

An in-depth look at Dubai Investments PJSC's financial performance and strategic initiatives over recent years.

Dubai Investments PJSC announces a 25% cash dividend and elects new board members, reflecting strong financial performance and strategic growth.